Population impact of direct-acting antiviral treatment on new presentations of hepatitis C-related decompensated cirrhosis: a national record-linkage study

Sharon J Hutchinson,David Goldberg,Shanley Smith,Kevin Pollock,Raymond Fox,Amanda Weir,Nicholas Kennedy,Kate Templeton,Scott A Mcdonald,Allan Mcleod,Hamish Innes,Rory N Gunson,Stephen Barclay,Peter Bramley,Heather Valerio,Alan Yeung,John F Dillon,Peter C Hayes,Andrew Fraser

doi:10.1136/gutjnl-2019-320007

Population impact of direct-acting antiviral treatment on new presentations of hepatitis C-related decompensated cirrhosis: a national record-linkage study

Sharon J Hutchinson, David Goldberg + Show 17 more

Open Access

https://doi.org/10.1136/gutjnl-2019-320007

Copy DOI

Journal: Gut	Publication Date: Mar 26, 2020
Citations: 17	License type: other-oa

Affiliation: Glasgow Caledonian University, Health Protection Scotland, Monklands Hospital, Edinburgh Royal Infirmary, Glasgow Royal Infirmary, University of Stirling, Ninewells Hospital, Aberdeen Royal Infirmary, Queen Elizabeth University Hospital

#Direct-acting Antiviral #Direct-acting Antiviral Era + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

ObjectivePopulation-based studies demonstrating the clinical impact of interferon-free direct-acting antiviral (DAA) therapies are lacking. We examined the impact of the introduction of DAAs on HCV-related decompensated cirrhosis (DC) through analysis...

Full Text